44 reports

February 2018 The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area Healthcare TABLE OF CONTENTS TABLE OF CONTENTS Introduction 2017 HIGHLIGHTS IN BIOPHARMACEUTICAL R& D INCLUDED HIGH-PROFILE SUCCESSES AND FAILURES FOR THE BIOPHARMACEUTICAL INDUSTRY, ##

  • Biopharmaceutical
  • Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC

OTHER APPLICATIONS MARKET SEGMENTATION BY END USER BIOPHARMACEUTICAL COMPANIES Biopharmaceutical companies advances in genetics research to develop products for human diseases and conditions.

  • Biopharmaceutical
  • Medical Biotechnology
  • World
  • Forecast
  • AstraZeneca PLC

These newly launched products currently average revenue of $##M in 2017 but are expected The fourth wave includes large-cap players such as Shire, Novo Nordisk, and Eli Lilly, but also many small-cap bio/ pharma companies or private bio/ pharma companies with only

  • Biopharmaceutical
  • Biosimilar
  • AbbVie Inc.
  • Alexion Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Breast Cancer Therapeutics Market, Global, All Pipeline Products, Pre-registration,
  • Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase II, 2018

Gland Surgery; ##(##): ##-## Zhang P, et al. (2016).

  • Biopharmaceutical
  • Breast Cancer
  • Targeted Therapy
  • Therapy
  • AstraZeneca PLC

TABLE ##: ABEONA THERAPEUTICS PRODUCT PIPELINE BUSINESS OVERVIEW Oxford Biomedica Oxford Biomedica is a cell and gene based biopharmaceutical company headquartered in UK.

  • Biopharmaceutical
  • Gene Therapy
  • Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH

Patients in the ERASURE study were randomized ##:##:## to receive subcutaneous Cosentyx ##mg, ##mg, or placebo, whereas the FIXTURE trial had an additional comparative arm of etanercept ##mg dosed twice weekly (##:##:##:##).

  • Autoimmune Disease
  • Biopharmaceutical
  • Therapy
  • Market Size
  • AstraZeneca PLC

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Biopharmaceutical
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • AstraZeneca PLC
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, LICENSING DEALS, 2006-2017 (PART 3)
  • Latest stage of development

DNX Biopharmaceuticals Inc.

  • Biopharmaceutical
  • Dermatological Condition
  • Dermatology
  • Therapy
  • AstraZeneca PLC
  • Breast Cancer Therapeutics Market, Global, All Pipeline Products, Phase I, 2016
  • varlilumab

It was developed by Galena Biopharma.

  • Biopharmaceutical
  • Breast Cancer
  • Therapy
  • Forecast
  • AstraZeneca PLC
  • Chapter 2: The Status of the Global Biopharmaceutical Market
  • Top R&D Spenders in the Pharmaceutical Industry - 2014-2016, (millions of $)

FIGURE ##-##: PROJECTED OPPORTUNITIES IN SIX MAJOR BIOPHARMACEUTICAL SPECIALTIES, 2010-2022 Chapter ##: Executive Summary Market Outlook Chapter ##: The Status of the Global Biopharmaceutical Market Chapter ##: The Status of the Global Biopharmaceutical Market

  • Biopharmaceutical
  • Targeted Therapy
  • Therapy
  • World
  • AstraZeneca PLC

In January 2010, Galapagos, a bio-pharmaceuticals company, entered into a global multi-year strategic alliance with Roche to develop novel treatments for COPD.

  • Biopharmaceutical
  • Therapy
  • Market Size
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH

Head & Neck Oncology; ##(##): ## Globocan.

  • Biopharmaceutical
  • Cancer
  • Chemotherapy
  • Therapy
  • AstraZeneca PLC
  • KEY EVENTS IMPACTING SALES FOR RA IN THE US, 2015-2025
  • COMPARISON OF THERAPEUTIC DRUG CLASSES IN DEVELOPMENT FOR RA, 2016

IN JUNE 2016, CAN-FITE BIOPHARMA ANNOUNCED THAT IT HAD REACHED AN AGREEMENT WITH THE EMA FOR CF-##' S PHASE III TRIAL DESIGN (CAN-FITE BIOPHARMA; PRESS RELEASE; JUNE ##, 2016).

  • Biopharmaceutical
  • Australasia
  • Australia
  • Forecast
  • AstraZeneca PLC
  • Dermatology Therapeutics, Global, Licensing Deals with Disclosed Deal Values, 2006-2017 (Part 2)
  • Dermatology Therapeutics, Global, Licensing Deals with Disclosed Deal Values, 2006-2017 (Part 1)

This realization has paved the way for a gradual paradigm shift, first in the scientific community and increasingly in the biopharmaceutical landscape.

  • Biopharmaceutical
  • Dermatology
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC

RCC Market Patent Trend by Top Inventors Merck ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer ## ## ## ## ## ## ## ## ## ## ## ## ## ## Roche ## ## ## ## ## ## ## ## ## ## ## ## ## ## NIH ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Genentech ## ## ## ## ## ## ## ## ##

  • Biopharmaceutical
  • Cancer
  • Renal Cancer
  • Therapy
  • AstraZeneca PLC

Lung India; ##(##): ##-## AIHW (2016).

  • Asthma
  • Biopharmaceutical
  • Therapy
  • Market Size
  • AstraZeneca PLC

PLoS One; ##(##): e## Lee P, et al. (2012).

  • Biopharmaceutical
  • Lung Cancer
  • Therapy
  • Market Size
  • AstraZeneca PLC
  • ONCOLOGY, GLOBAL, CO-DEVELOPMENT DEALS BY MOLECULE TYPE AND MECHANISM OF ACTION, 2006-2017

Vor BioPharma Inc..

  • Biopharmaceutical
  • Oncology
  • Company Financials
  • Market Size
  • AstraZeneca PLC

Xbrane Biopharma AB Can-Fite BioPharma Ltd.

  • Biopharmaceutical
  • Pharmaceutical
  • Therapy
  • Market Size
  • AstraZeneca PLC

Bayer is a global leader in the healthcare and biopharmaceuticals markets.

  • Biopharmaceutical
  • Cancer
  • Targeted Therapy
  • Therapy
  • AstraZeneca PLC
  • 9.2 INNOVATIVE EARLY-STAGE APPROACHES

TREATMENT DAYS: GAZYVA IS ADMINISTERED AT A DOSE OF ##, ##MG IV ON DAYS ##/ ##, ##, AND ## OF CYCLE ##, AND ON DAY ## OF CYCLES ##-##.

  • Biopharmaceutical
  • North America
  • United States
  • Forecast
  • AstraZeneca PLC

NGM BIOPHARMACEUTICALS, BRISTOL-MYERS SQUIBB, COHBAR, INC.

  • Biomarker
  • Biopharmaceutical
  • Therapy
  • Allergan plc
  • AstraZeneca PLC

Product REZEPTA BIOPHARMA ID No.

  • Biopharmaceutical
  • Cancer Immunotherapy
  • Therapy
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company

ANTHERA IS A SMALL US-BASED BIOPHARMACEUTICAL COMPANY WITH NO MARKETED PRODUCTS AND TWO PHASE III PIPELINE DRUGS.

  • Biopharmaceutical
  • Epidemiology
  • Therapy
  • World
  • AstraZeneca PLC

MAX BIOPHARMA ##.

  • Biopharmaceutical
  • North America
  • United States
  • Demand
  • AstraZeneca PLC

However, there is also a significant presence of smaller biopharma companies, such as Kite Pharma, Juno Therapeutics and Incyte Corporation.

  • Biopharmaceutical
  • Cancer Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • AstraZeneca PLC
  • targets

Sun BioPharma, Inc.

  • Biopharmaceutical
  • Cancer
  • Oncology
  • Therapy
  • AstraZeneca PLC

Name SSS##; TRPH ##; TPMC-##; DIG-KT Target / Mechanism of Action ## ## WUHAN YZY BIOPHARMA - ##/ ## ID No.

  • Biopharmaceutical
  • Cancer
  • Immunotherapy
  • Affimed Therapeutics AG
  • AstraZeneca PLC

This agreement enables Galena Biopharma to expand clinical utility and the commercial footprint of NeuVax in the treatment of breast and gastric cancers. ##. ##. ##. ## Agenus Acquires Rights to Anti-CEACAM## Antibodies from Diatheva ##. ##. ##. ## Array BioPharma Licenses Cancer Drug ARRY-## to

  • Biopharmaceutical
  • Gastric Cancer
  • Therapy
  • AstraZeneca PLC
  • Roche Group

Name SSS##; TRPH ##; TPMC-##; DIG-KT Target / Mechanism of Action ## ## WUHAN YZY BIOPHARMA - ##/ ## ID No.

  • Biopharmaceutical
  • Cancer
  • Immunotherapy
  • Affimed Therapeutics AG
  • AstraZeneca PLC